Similar articles

• Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children.

  Cryz SJ Jr, Vanprapar N, Thisyakorn U, Olanratmanee T, Losonsky G, Levine MM, Chearskul S. Cryz SJ Jr, et al. Infect Immun. 1993 Mar;61(3):1149-51. doi: 10.1128/iai.61.3.1149-1151.1993. Infect Immun. 1993. PMID: 8432597 Free PMC article. Clinical Trial.
• Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.

  Simanjuntak CH, Paleologo FP, Punjabi NH, Darmowigoto R, Soeprawoto, Totosudirjo H, Haryanto P, Suprijanto E, Witham ND, Hoffman SL. Simanjuntak CH, et al. Lancet. 1991 Oct 26;338(8774):1055-9. doi: 10.1016/0140-6736(91)91910-m. Lancet. 1991. PMID: 1681365 Clinical Trial.
• Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a.

  Darton TC, Jones C, Blohmke CJ, Waddington CS, Zhou L, Peters A, Haworth K, Sie R, Green CA, Jeppesen CA, Moore M, Thompson BA, John T, Kingsley RA, Yu LM, Voysey M, Hindle Z, Lockhart S, Sztein MB, Dougan G, Angus B, Levine MM, Pollard AJ. Darton TC, et al. PLoS Negl Trop Dis. 2016 Aug 17;10(8):e0004926. doi: 10.1371/journal.pntd.0004926. eCollection 2016 Aug. PLoS Negl Trop Dis. 2016. PMID: 27533046 Free PMC article. Clinical Trial.
• [The problem of designing typhoid vaccines].

  Tymchuk SN, Boĭchenko MN, Vorob'ev AA. Tymchuk SN, et al. Zh Mikrobiol Epidemiol Immunobiol. 1996 Jul-Aug;(4):86-90. Zh Mikrobiol Epidemiol Immunobiol. 1996. PMID: 9027185 Review. Russian. No abstract available.
• Host-Salmonella interaction: human trials.

  Levine MM, Tacket CO, Sztein MB. Levine MM, et al. Microbes Infect. 2001 Nov-Dec;3(14-15):1271-9. doi: 10.1016/s1286-4579(01)01487-3. Microbes Infect. 2001. PMID: 11755415 Review.